Coherus Oncology (CHRS) Asset Utilization Ratio (2014 - 2026)

Coherus Oncology has disclosed Asset Utilization Ratio across 13 years of filings, most recently posting 0.18 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.18, up 131.31% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.18 (up 131.31% YoY), and the FY2025 annual result was 0.12, up 143.74% from the prior year.
• Asset Utilization Ratio came in at 0.18 for Q1 2026 at Coherus Oncology, up from 0.11 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.48 in Q2 2022 to a low of 0.06 in Q4 2024.
• The 5-year median for Asset Utilization Ratio is 0.33 (2024), against an average of 0.28.
• Across the five-year window, Asset Utilization Ratio tumbled 86.95% in 2024 and surged 131.31% in 2026, its largest moves.
• Coherus Oncology's Asset Utilization Ratio stood at 0.41 in 2022, then grew by 3.65% to 0.42 in 2023, then sank by 86.95% to 0.06 in 2024, then soared by 96.66% to 0.11 in 2025, then jumped by 64.28% to 0.18 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.18 (Q1 2026), 0.11 (Q4 2025), and 0.08 (Q3 2025), per Business Quant data.